Patent Assignment
Reel/Frame 043029/0302
Change of Name
Recorded: 2017-06-28
Pages: 4
Assignor
ISIS PHARMACEUTICALS, INC.
Executed: 2015-12-18
Assignee
IONIS PHARMACEUTICALS, INC.
2855 GAZELLE COURT, CARLSBAD, CALIFORNIA, 92010
Covered Properties
(10)
Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
Double Stranded Constructs Comprising One or More Short Strands Hybridized to a Longer Strand
Carbocyclic Alpha-L-Bicyclic Nucleic Acid Analogs
Modulation of Growth Hormone Receptor Expression and Insulin-Like Growth Factor Expression
Cyclohexenyl Nucleic Acids Analogs
Proinflammatory Nucleic Acids
Modulation of Exportin 5 Expression
Antibacterial 4,5-Substituted Aminoglycoside Analogs Having Multiple Substituents
Supports for Oligomer Synthesis
Antisense Oligonucleotide Modulation of STAT3 Expression
Related Assignments
(1)
Other recorded transfers of the patents in this record — the chain of ownership.